Wells Fargo’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Sell
32,281
-43,826
-58% -$282K ﹤0.01% 4620
2025
Q4
$429K Buy
76,107
+30,900
+68% +$167K ﹤0.01% 4604
2025
Q3
$279K Buy
45,207
+2,845
+7% +$16.6K ﹤0.01% 4726
2025
Q2
$206K Buy
42,362
+28,221
+200% +$99.8K ﹤0.01% 4749
2025
Q1
$52.3K Buy
14,141
+1,003
+8% +$4.29K ﹤0.01% 5378
2024
Q4
$52.6K Buy
13,138
+2,986
+29% +$16.4K ﹤0.01% 5467
2024
Q3
$70.8K Buy
10,152
+237
+2% +$1.92K ﹤0.01% 5203
2024
Q2
$56.2K Buy
9,915
+9,751
+5,946% +$87.3K ﹤0.01% 5250
2024
Q1
$2.18K Buy
164
+89
+119% +$833 ﹤0.01% 6019
2023
Q4
$461 Buy
75
+6
+9% +$19 ﹤0.01% 6402
2023
Q3
$174 Sell
69
-56
-45% -$217 ﹤0.01% 6621
2023
Q2
$655 Buy
125
+2
+2% +$11 ﹤0.01% 6429
2023
Q1
$583 Buy
123
+29
+31% +$174 ﹤0.01% 6514
2022
Q4
$506 Hold
94
﹤0.01% 6382
2022
Q3
$0 Sell
94
-117
-55% -$1.18K ﹤0.01% 7283
2022
Q2
$2K Sell
211
-543
-72% -$5.64K ﹤0.01% 6372
2022
Q1
$13K Sell
754
-1,459
-66% -$25.7K ﹤0.01% 6181
2021
Q4
$58K Buy
2,213
+588
+36% +$18K ﹤0.01% 5899
2021
Q3
$58K Sell
1,625
-3,114
-66% -$132K ﹤0.01% 5565
2021
Q2
$259K Buy
4,739
+460
+11% +$30.4K ﹤0.01% 4921
2021
Q1
$354K Sell
4,279
-2,707
-39% -$299K ﹤0.01% 4874
2020
Q4
$795K Buy
6,986
+3,953
+130% +$250K ﹤0.01% 4194
2020
Q3
$92K Sell
3,033
-3,659
-55% -$140K ﹤0.01% 5301
2020
Q2
$294K Sell
6,692
-1,653
-20% -$68.6K ﹤0.01% 4676
2020
Q1
$299K Buy
8,345
+3,397
+69% +$168K ﹤0.01% 4415
2019
Q4
$331K Buy
4,948
+3,913
+378% +$432K ﹤0.01% 4674
2019
Q3
$160K Buy
1,035
+312
+43% +$35.3K ﹤0.01% 5093
2019
Q2
$62K Sell
723
-67
-8% -$7.31K ﹤0.01% 5477
2019
Q1
$108K Buy
790
+9
+1% +$2.25K ﹤0.01% 5103
2018
Q4
$315K Buy
781
+232
+42% +$109K ﹤0.01% 4639
2018
Q3
$389K Buy
549
+260
+90% +$163K ﹤0.01% 4609
2018
Q2
$155K Buy
289
+40
+16% +$12.3K ﹤0.01% 5162
2018
Q1
$28K Buy
+249
New +$84.1K ﹤0.01% 5734

Other funds holding SLDB